These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 8191763

  • 1. Hormonal therapy for metastatic prostate cancer.
    Small EJ.
    West J Med; 1994 Mar; 160(3):253-4. PubMed ID: 8191763
    [No Abstract] [Full Text] [Related]

  • 2. Hormonal approaches in prostate cancer: application in the contemporary prostate cancer patient.
    Beekman KW, Hussain M.
    Urol Oncol; 2008 Mar; 26(4):415-9. PubMed ID: 18593620
    [Abstract] [Full Text] [Related]

  • 3. [Role of hormonotherapy in the treatment of metastatic prostate cancer].
    Lebret T, Méjean A.
    Prog Urol; 2008 Nov; 18 Suppl 7():S332-7. PubMed ID: 19070812
    [Abstract] [Full Text] [Related]

  • 4. [Complete androgen blockage in the treatment of metastatic prostate cancer].
    Matzkin H, Braf Z.
    Harefuah; 1994 Mar 01; 126(5):260-3. PubMed ID: 8188104
    [No Abstract] [Full Text] [Related]

  • 5. Immunomagnetic quantification of circulating tumor cells as a prognostic factor of androgen deprivation responsiveness in patients with hormone naive metastatic prostate cancer.
    Okegawa T, Nutahara K, Higashihara E.
    J Urol; 2008 Oct 01; 180(4):1342-7. PubMed ID: 18707699
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. New agents in metastatic prostate cancer.
    Fizazi K, Massard C.
    Eur J Cancer; 2009 Sep 01; 45 Suppl 1():379-80. PubMed ID: 19775638
    [No Abstract] [Full Text] [Related]

  • 17. Randomized comparison of total androgen blockade alone versus combined with weekly epirubicin in advanced prostate cancer.
    Pummer K, Lehnert M, Stettner H, Hubmer G.
    Eur Urol; 1997 Sep 01; 32 Suppl 3():81-5. PubMed ID: 9267791
    [Abstract] [Full Text] [Related]

  • 18. This paper evaluates the natural history of prostate cancer in heterogeneous cohort of men treated with HT.
    Yossepowitch O.
    Eur Urol; 2007 Aug 01; 52(2):453. PubMed ID: 17674435
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.